Trial intelligence / Profile preview

Short-term topiramate effects on insulin secretion and metabolism in obese women

2006-004373-10Phase 4Active

Sponsor
TOP Institute of Pharmaceutical Research
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of topiramate in obesity and diabetes mellitus (DM) (2 arms), sponsored by TOP Institute of Pharmaceutical Research. Started Feb 2008; status: active.

02

Drugs

topiramate
03

Conditions

obesitydiabetes mellitus (DM)

Beyond the preview

Go deeper on 2006-004373-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004373-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call